PTEN and leukemia: In contrast, deletion of PRL2 in the PTEN HET mice resulted in an approximately 30% increase in the amount of PTEN protein and a concomitant reduction in AKT pathway activation, a slower rate of LSC accumulation within the BM, and a delayed onset of severe leukemia phenotypes relative to the PTEN HET counterparts.